News Focus
News Focus
icon url

weaver 2

10/06/18 7:55 PM

#40247 RE: holter49 #40246

the orphan designation is real, the products are real and work even if they are old batches. the patents are real. the scientists that developed the products were authentic. I don't know how that translates into value for stock holders but you got to think the above is worth at least the stock price probably more..
icon url

Goofy R

10/07/18 4:18 PM

#40252 RE: holter49 #40246

That's a very good question Holter49; however, if...

the potential for the drug is as good as we hope/hoped, why haven't any REAL pharma companies stepped forward to try and buy NPHC?

Seems VERY logical that a big pharma company would love to take on NPHC's debt obligations and pay for the trials if there was any REAL potential for the drug applications...

What's $5-10 Million -- or even $20 million -- for a big pharma company? NOTHING!!

So, there's that...

Or... perhaps they would be TERRIFIED of what else Rik could be hiding underneath this company.

As a wise one on this board says:

"Thinking"
icon url

flaflyersfan

10/08/18 7:47 AM

#40253 RE: holter49 #40246

holter49, orphan drugs by definition are drugs that you cannot make money on;

He used it for hype...for years.

Good luck.